Se-Jin Kim

6PUBLICATIONS
11CO-AUTHORS
Medical mycologyTumour immunologyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2026
An MR1-specific nanobody capable of blocking MR1T cell activation.

|Apr 14, 2026
Synaptotagmin 1 and Synaptotagmin 7 promote MR1-mediated presentation of Mycobacterium tuberculosis antigens.

Se-Jin Kim, Jessie C Peterson, Andrew J Olive

|Feb 27, 2026
Opposing roles for SNAP23 and SNAP25 in mediating MR1 trafficking and antigen presentation.

Se-Jin Kim, Corinna A Kulicke, David M Lewinsohn

|Feb 09, 2026
Antigenic stimulation in conjunction with cytokine is required for mediating IL-17A production in human MAIT cells.

Se-Jin Kim, Dylan Kain, Deborah A Lewinsohn

|Jul 16, 2025
Synaptotagmin 1 and Synaptotagmin 7 promote MR1-mediated presentation of Mycobacterium tuberculosis antigens.

Se-Jin Kim, Jessie C Peterson, Andrew J Olive

|Nov 26, 2022
MR1- and HLA-E-Dependent Antigen Presentation of Mycobacterium tuberculosis.

Se-Jin Kim, Elham Karamooz

Pageof 1

Frequent Collaborators

2 joint publications

Fikadu G Tafesse

2 joint publications

Corinna A Kulicke

2 joint publications

David M Lewinsohn

1 joint publications

Andrew J Olive